feed,title,long_url,short_url
SeekingAlpha,Charles River Laboratories beats Q4 top and bottom line estimates; initiates FY23 outlook,https://seekingalpha.com/news/3938931,
SeekingAlpha,Ionis Pharmaceuticals reports Q4 results,https://seekingalpha.com/news/3938930,
SeekingAlpha,"Travel + Leisure stock lifts off on profit beat, optimistic outlook",https://seekingalpha.com/news/3938929,
SeekingAlpha,Mortgage applications falls for fourth week as interest rates surge,https://seekingalpha.com/news/3938927,
SeekingAlpha,Sage's therapy for Huntington's disease gets orphan drug status in EU,https://seekingalpha.com/news/3938925,
SeekingAlpha,The Brink's reports Q4 earnings; initiate FY23 outlook,https://seekingalpha.com/news/3938926,
